Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Found vs No BS RX

By GLP-1 ScorecardUpdated

FoundFactor scores not reassessed.
Site position #7

Higher score

No BS RXFactor scores not reassessed.
Site position #23

Lower score

Score comparison

Found has the higher recorded score — 83.5/100 to 82.8/100, but only just.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra. No BS RX is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the Found review and the No BS RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Found vs Noom Med and Fridays vs No BS RX compare each of them with another graded program, and the list of alternatives to Found ranks the programs closest to Found on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +14
78
92
Dose & formulationFound +4
94
90
Clinical oversightFound +14
86
72
Labs & monitoringFound +14
82
68
FulfillmentNo BS RX +10
84
94
Contract termsNo BS RX +4
70
74
Found · top barNo BS RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFoundNo BS RX
WeighScore83.5/10082.8/100
GradeBB−
Site position#7#23
Semaglutide$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)$149/mo advertised for standard compounded injection; low-dose priced separately
Tirzepatide$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)$225/mo advertised for standard compounded injection; low-dose priced separately
CoverageU.S. service with state, treatment and insurance restrictions; confirm your eligibilityConfirm program availability for your state
Brand-name accessYesYes
Oral / sublingualYesYes
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period

Featured provider

Found

Factor scores not reassessed.

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard